Nearly 300 leading U.S. disease experts expressed serious concern about the White House’s inadequate budget request for global AIDS and TB programs, saying the proposed funding levels signal a retreat in the U.S. response to the twin epidemics of HIV and TB. In a strongly-worded letter sent to members of Congress today, the physician-scientists said […]
HIV
Amid unprecedented challenges to routine healthcare access, trial results mark a first for a critically needed HIV prevention measure An investigational drug administered by injection every […]
Tuberculosis
In the six weeks before South Africa responded its first diagnoses of COVID-19 with the start of physical distancing measures, more than 47,000 people on average […]
Research & Development
With 2018 data showing highest incidence acute flaccid myelitis since monitoring began, officials say awareness, recognition of rare life threatening condition will be crucial to early […]
Policy
The following is a guest post by Kenneth G. Castro, MD, FIDSA Since its formation in 1948, WHO has relied heavily on the U.S. for collaborations […]